Moore Kuehn, PLLC Encourages Investors of Vroom, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - September 20, 2021) - Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating potential claims involving directors and officers regarding possible breaches of fiduciary duties related to whether insiders caused their companies to make false and/or misleading statements and/or failed to disclose, among other things, that:• Vroom, Inc. (NASDAQ: VRM)(1) Vroom had not demonstrated that it was able to control and scale...
2021-09-20 10:44 AM EDT
Moore Kuehn, PLLC Encourages Investors of The Boston Beer Company, Inc. to Contact Law Firm
New York, New York--(Newsfile Corp. - September 16, 2021) - Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating potential claims involving directors and officers regarding possible breaches of fiduciary duties related to whether insiders caused their companies to make false and/or misleading statements and/or failed to disclose, among other things, that:• The Boston Beer Company, Inc. (NYSE: SAM)(1) that Boston Beer's hard seltzer sales were decelerating; (2)...
2021-09-16 12:32 PM EDT
Moore Kuehn, PLLC Encourages Investors of Pershing Square Tontine Holdings, Ltd. or PSTH to Contact Law Firm
New York, New York--(Newsfile Corp. - August 17, 2021) - Moore Kuehn PLLC, a boutique shareholder derivative law firm, handling investor litigation across the northeast and the country, is investigating potential breach of fiduciary duty claims against Pershing Square Tontine Holdings, Ltd. Pershing Square Tontine Holdings, Ltd. ("Pershing Square Tontine" or the "Company") (NYSE: PSTH). Officers, directors, and controlling shareholders owe fiduciary duties of utmost good faith, scrupulous honesty, and loyalty to the corporation and to its shareholders...
2021-08-17 4:13 PM EDT
Moore Kuehn, PLLC Encourages Investors of FREQ to Contact Law Firm
New York, New York--(Newsfile Corp. - August 12, 2021) - Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating potential claims involving directors and officers regarding possible breaches of fiduciary duties related to whether insiders caused their companies to make false and/or misleading statements and/or failed to disclose, among other things, that:• Frequency Therapeutics Inc. (NASDAQ: FREQ)The company or its officers and directors made materially false and misleading statements and/or failed to disclose that: (1) Frequency's...
2021-08-12 4:06 PM EDT
Moore Kuehn, PLLC Encourages Investors of ACRX to Contact Law Firm
New York, New York--(Newsfile Corp. - August 12, 2021) - Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating potential claims involving directors and officers regarding possible breaches of fiduciary duties related to whether insiders caused their companies to make false and/or misleading statements and/or failed to disclose, among other things, that:AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX)The company or its officers and directors made false and/or misleading statements and/or failed to disclose that: (1) the Company had...
2021-08-12 4:01 PM EDT
Moore Kuehn, PLLC Encourages Investors of OCGN to Contact Law Firm
New York, New York--(Newsfile Corp. - August 12, 2021) - Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating potential claims involving directors and officers regarding possible breaches of fiduciary duties related to whether insiders caused their companies to make false and/or misleading statements and/or failed to disclose, among other things, that:Ocugen, Inc. (NASDAQ: OCGN)The company or its officers and directors made materially false and misleading statements and/or failed to disclose that: (1) the information submitted...
2021-08-12 3:59 PM EDT
Moore Kuehn Encourages BSTC Investors to Contact Law Firm
New York, New York--(Newsfile Corp. - November 13, 2020) - Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether BioSpecifics Technologies Corp. (NASDAQ: BSTC) agreement to be acquired by Endo International PLC is fair to shareholders.Under the terms of the agreement, a tender offer expiring on December 2nd was commenced by Endo International to acquire BioSpecifics Technologies for $88.50 per share. The solicitation...
2020-11-13 2:10 PM EST